Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | | 2.71M | $49.77M | - |
| CEO | ROBINS CHAD M | 2.58M | $47.47M | -124,998 |
| Other | | 1.23M | $22.64M | - |
| Other | ROBINS HARLAN S | 1.22M | $22.45M | -10,000 |
| COO | RUBINSTEIN JULIE | 607.7K | $11.16M | - |
Transactions
50 transactions · page 12
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2020-11-16 | GRIFFIN MICHELLE RENEE | Director | Sale+OE | 6,000 | $47.69 | $286,134.67 | -86.0% | → |
| 2020-11-11 | VIKING GLOBAL INVESTORS LP | - | Sell | 2,500,000 | $49.52 | $123,787,500.00 | -7.5% | → |
| 2020-11-11 | VIKING GLOBAL PERFORMANCE LLC | - | Sell | 2,500,000 | $49.52 | $123,787,500.00 | -7.5% | → |
| 2020-11-09 | Cohen Chad M | Chief Financial Officer | Sale+OE | 30,000 | $49.16 | $1,474,705.44 | -63.0% | → |
| 2020-11-06 | BALDO LANCE | Chief Medical Officer | Sale+OE | 6,250 | $50.63 | $316,448.84 | -88.7% | → |
| 2020-11-06 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 33,300 | $50.70 | $1,688,247.48 | -62.0% | → |
| 2020-11-02 | BENZENO SHARON | Chief Business Development Off | Sale+OE | 6,772 | $45.58 | $308,642.42 | -86.3% | → |
| 2020-10-26 | Taylor Stacy L | SVP and General Counsel | Sale+OE | 2,880 | $49.78 | $143,359.50 | -37.2% | → |
| 2020-10-19 | BENZENO SHARON | Chief Business Development Off | Sale+OE | 417 | $51.25 | $21,371.25 | -100% | → |
| 2020-10-16 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 11,100 | $51.79 | $574,869.00 | -94.2% | → |
| 2020-10-15 | LO FRANCIS | Chief People Officer | Sale+OE | 2,000 | $51.51 | $103,020.00 | -100% | → |
| 2020-10-15 | HERSHBERG ROBERT | Director | Sale+OE | 2,000 | $51.51 | $103,020.00 | -100% | → |
| 2020-10-15 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 22,200 | $51.86 | $1,151,337.60 | -80.1% | → |
| 2020-10-14 | GRIFFIN MICHELLE RENEE | Director | Sale+OE | 12,000 | $52.84 | $634,097.09 | -62.0% | → |
| 2020-10-14 | Pellini Michael J | Director | Sale+OE | 50,000 | $52.35 | $2,617,549.70 | -69.7% | → |
| 2020-10-12 | LO FRANCIS | Chief People Officer | Sale+OE | 25,000 | $52.80 | $1,320,000.00 | -100% | → |
| 2020-10-08 | Cohen Chad M | Chief Financial Officer | Sale+OE | 30,000 | $50.65 | $1,519,428.60 | -78.4% | → |
| 2020-10-08 | ROBINS CHAD M | CEO and Chairman | Sale+OE | 92,540 | $50.13 | $4,639,102.48 | -0.9% | → |
| 2020-10-06 | BALDO LANCE | Chief Medical Officer | Sale+OE | 6,250 | $49.20 | $307,518.16 | -75.6% | → |
| 2020-10-01 | BENZENO SHARON | Chief Business Development Off | Sale+OE | 6,771 | $48.57 | $328,837.06 | -88.3% | → |
| 2020-10-01 | DOBMEIER ERIC | Director | Sale+OE | 10,000 | $48.53 | $485,274.24 | -92.8% | → |
| 2020-10-01 | RUBINSTEIN JULIE | President | Sale+OE | 14,725 | $49.00 | $721,525.00 | -100% | → |
| 2020-10-01 | ROBINS CHAD M | CEO and Chairman | Sale+OE | 600 | $50.05 | $30,030.00 | - | → |
| 2020-09-29 | BALDO LANCE | Chief Medical Officer | Sale+OE | 25,000 | $50.00 | $1,250,000.00 | -100% | → |
| 2020-09-29 | BOBULSKY SUSAN | SVP, Diagnostics, clonoSEQ | Sale+OE | 10,000 | $50.00 | $500,000.00 | -100% | → |